Day: February 8, 2022

Oslo, 8 February 2022: The Board of Directors of Yara International ASA has decided to propose to the Annual General Meeting an ordinary dividend for 2021 of NOK 30.00 per share. The following are the key dates if the dividend is approved by the Annual General Meeting: Dividend amount: 30.00 per shareDeclared currency: NOKLast day including right: 10 May 2022Ex-date: 11 May 2022Record date: 12 May 2022Payment date: 20 May 2022ADR payment date: 27 May 2022Date of approval: 10 May 2022 Contact Silje NygaardHead of Investor RelationsMobile: +47 957 04 843E-mail: silje.nygaard@yara.com About YaraYara grows knowledge to responsibly feed the world and protect the planet. Supporting our vision of a world without hunger and a planet respected, we pursue a strategy of sustainable value growth, promoting climate-friendly crop nutrition and zero-emission...

Crypto Blockchain Industries (CBI) and the Horyou Foundation join forces to create a metaverse and token focused on humanitarian action and preserving the planet Creation of a vast Horyou universe within AlphaVerse Issuing of a token to support digital philanthropy CRYPTO BLOCKCHAIN INDUSTRIES (CBI, Euronext Growth Paris: FR0014007LW0, ALCBI) is announcing an agreement with Horyou, a global platform promoting a more humanistic approach to technology by bringing together stakeholders promoting social good. Under this agreement, CBI will develop a dedicated universe – Horyou AlphaVerse – within its metaverse and NFTs to support the Horyou Foundation. The licensing partnership between CBI and Horyou includes two additional areas for development: creating a Horyou universe within AlphaVerse and selling dedicated NFTs for this universe,...

Oslo, 8 February 2022: Yara reports improved fourth-quarter results as increases in prices more than offset the impact of higher energy cost. Fourth-quarter EBITDA excluding special items1 was USD 765 million compared with USD 511 million a year earlier. Net income was a negative USD 26 million compared with a positive USD 246 million a year earlier, as Yara recognized impairment losses of USD 250 million, of which USD 232 million is related to the Dallol mining project in Ethiopia. Excluding currency effects and special items, basic earnings per share1 was USD 1.19 compared with USD 0.76 per share in fourth quarter 2020. The main elements of the fourth-quarter results are:Increased margins reflect business model resilience 7.9% ROIC1, in line with a year earlier as impairments offset margin growth NOK 30 per share annual dividend proposed;...

Talenom Plc, stock exchange release, 8 February 2022 at 9:00 EET TALENOM PLC’S FINANCIAL STATEMENT BULLETIN 2021: GROWTH ACCELERATED AND PROFITABILITY REMAINED EXCELLENT AS THE INTERNATIONALISATION STRATEGY PROGRESSED JANUARY–DECEMBER 2021 IN BRIEFNet sales EUR 82.8 million (65.2), growth 27.1% (12.4) EBITDA EUR 27.7 million (23.3), 33.4% (35.7) of net sales Operating profit (EBIT) EUR 14.8 million (12.9), 17.8% (19.8) of net sales Net profit EUR 10.8 million (9.6) Earnings per share EUR 0.25 (0.22) Board of Directors’ dividend proposal EUR 0.17 (0.15) per shareOCTOBER–DECEMBER 2021 IN BRIEFNet sales EUR 21.8 million (16.5), growth 32.2% (10.4) EBITDA EUR 6.6 million (5.0), 30.4% (30.7) of net sales Operating profit (EBIT) EUR 2.8 million (2.4), 12.8% (14.7) of net sales Net profit EUR 1.9 million (1.8) Earnings per share...

TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) — International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) today released its financial and operating results and related management’s discussion and analysis (MD&A) for the year ended December 31, 2021. IPC is also pleased to announce its 2022 capital expenditure budget of USD 127 million and its 2022 production guidance of between 46,000 and 48,000 barrels of oil equivalent (boe) per day (boepd).(1) 2021 year-end proved plus probable (2P) reserves and best estimate contingent resources (unrisked) are respectively 270 million boe (MMboe) and 1,410 MMboe.(1)(2)IPC forecasts cumulative free cash flow (FCF) for 2022 to 2026 of approximately MUSD 900 to MUSD 1,800 (based on forecast Brent oil prices of USD 65 to 95 per barrel) generating estimated average...

International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) today released its financial and operating results and related management’s discussion and analysis (MD&A) for the year ended December 31, 2021. IPC is also pleased to announce its 2022 capital expenditure budget of USD 127 million and its 2022 production guidance of between 46,000 and 48,000 barrels of oil equivalent (boe) per day (boepd).(1) 2021 year-end proved plus probable (2P) reserves and best estimate contingent resources (unrisked) are respectively 270 million boe (MMboe) and 1,410 MMboe.(1)(2)IPC forecasts cumulative free cash flow (FCF) for 2022 to 2026 of approximately MUSD 900 to MUSD 1,800 (based on forecast Brent oil prices of USD 65 to 95 per barrel) generating estimated average annual FCF yield over the five year period of between...

Press ReleaseNicox’s Positive FDA Meeting Shows Clear Path for NCX 4251 in Dry EyeStatistically significant and clinically relevant results were obtained for the reduction of dry eye symptoms in patients with moderate to severe dry eye disease in a post hoc analysis of the Phase 2b Mississippi clinical trial A path forward to develop NCX 4251 as a treatment for dry eye disease has been confirmed following a recent meeting with the United States Food and Drug AdministrationFebruary 8, 2022 – release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that it will be focusing the future development of NCX 4251 on dry eye disease. This decision follows the encouraging post hoc results from the Mississippi Phase 2b clinical trial and a...

Ambu posted revenue for Q1 equal to the first quarter of last year, with organic growth of -1% and reported growth of 2%. Adjusted for last year’s NHS safety-stock orders, the Visualization business grew 26% in sales and 46% in volume reaching a new high with 419,000 units sold. Full-year outlook revised due to uncertainties created by Omicron. “I am pleased to report that we have matched last year’s Q1 record sales driven by the rapid growth of our ENT and urology businesses. Ambu is also expanding its presence in GI with the launch of our single-use gastroscope into one of the largest endoscopy segments with more than 20 million procedures globally. We continue to lead the creation of the single-use endoscopy market in the midst of significant disruptions due to the Omicron variant and remain committed to fulfil our aspiration of becoming...

Estimated revenue reaches over CAD$31 million (a record NIS 77 million) Anticipates continued increases in adjusted operating profit and EBITDA Revenue growth expected to continue throughout 2022 TORONTO and HERZLIYA, Israel, Feb. 08, 2022 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (“InterCure” or the “Company”) today announced record preliminary financial results for the fourth quarter of 2021. All amounts are expressed in Canadian dollars ($) or New Israeli Shekels (NIS), unless otherwise noted. Preliminary Fourth Quarter 2021 Financial Highlights and MilestonesRecord revenue estimated to be over $31 million (NIS 77 million), three times greater than the fourth quarter of 2020 and representing sequential growth of over 24%. Eighth consecutive quarter of high double-digit...